Search results for: hospital

FDA Approves Canakinumab to Treat Gout Flares

Michele B. Kaufman, PharmD, BCGP | November 3, 2023

Canakinumab has received FDA approval for the treatment of patients with acute gout flares.

FDA Accepts NDA for Investigational RA Agent

Michele B. Kaufman, PharmD, BCGP | November 1, 2023

The FDA has accepted an investigational new drug application (NDA) for MYMD-1, an oral tumor necrosis factor-α inhibitor for patients with rheumatoid arthritis.

When Is Arthroplasty Recommended? New ACR/AAHKS Guideline Offers Considerations for Timing of Elective Hip or Knee Arthroplasty

Ruth Jessen Hickman, MD | November 1, 2023

The ACR released a new arthroplasty guideline in an effort to remedy significant & detrimental delays faced by osteoarthritis or osteonecrosis patients who require surgical intervention.

Are We Making Progress in Treating Lupus? Clinical Insights from Dr. Michelle Petri

Jason Liebowitz, MD, FACR | November 1, 2023

At the 19th Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases course, Dr. Michelle Petri gave a presentation concerning the overall state of lupus treatment outcomes in the U.S.

Belimumab vs. Oral Immunosuppressants: Infection Risk in Patients with Non-Renal SLE

Arthritis & Rheumatology | November 1, 2023

Materne et al. aimed to compare the risk of infection among patients with non-renal SLE using the injectable immunosuppressant belimumab vs. an oral immunosuppressant, azathioprine, mycophenolate or methotrexate.

Get Your Patients Moving: Physical Activity Is Key for Pain Management & Overall Health

Vanessa Caceres | October 13, 2023

Regular movement is crucial for everyone, but patients with rheumatic disease may feel overwhelmed about starting and maintaining a routine. Here’s how physical and occupational therapists can help patients establish and reach movement goals, while improving their pain management and overall health.

Ethics Forum: Mitigation Tips for Health Disparities Among Rural & Indigenous Peoples

Laura Nichols, MD, Lee Graham, MD, & Erdal Diri, MD | October 12, 2023

A common case scenario in our practice in North Dakota is a woman with rheumatoid arthritis on methotrexate monotherapy. She is a member of the Sisseton Wahpeton Oyate people and lives 90 miles from our rheumatology clinic. She currently has moderate disease activity, indicating the need for additional treatment. She does not have her own…

Why Mental Health Screening Is Essential for Patients with Psoriatic Disease

Catherine Kolonko | October 12, 2023

Research suggests that patients with psoriasis and psoriatic arthritis (PsA) have a greater risk of depression, anxiety and, in some cases, substance abuse and dependence than the general population, yet symptoms often go unrecognized and untreated by medical professionals. Both psoriasis and PsA are associated with depression, with up to 30% of patients in either…

ACR’s Community Practice Council Supports Independent Practitioners

Dana Elise Rockwell, DO | October 12, 2023

Forging one’s own path after completing medical training can be daunting. As I entered the final six months of my rheumatology fellowship, I was also pregnant with my first child. Having grown comfortable within academic settings, I felt the nerves of trying to find my place outside medical education. Search for Home For the best…

Nurse Practitioners Deliver as Part of the Rheumatology Team

Leslie Mertz, PhD | October 12, 2023

The upcoming 2023 Nurse Practitioner Week, Nov. 12–18, was good reason for Debbie Durkee, RN, MSN, FNP-C, to reflect on the profession and its growth, her years in practice, and the importance of active participation in the ARP. Unlike many who go into the field, Ms. Durkee never felt drawn to nursing as a child,…